Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIg plus prednisone versus high-dose dexamethasone for adult immune thrombocytopenia with bleeding (IVIORDEX)
2021-000292-37Phase 3Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Apr 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial in immune thrombocytopenia (ITP) comparing IVIg plus prednisone with High-dose dexamethasone (2 arms). Primary endpoint: Time to initial response. Started Apr 2021; status: active.
02
Drugs
dexamethasonesubcuviaprednisone
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on 2021-000292-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000292-37.